Literature DB >> 9257823

Three domains of SLP-76 are required for its optimal function in a T cell line.

M A Musci1, D G Motto, S E Ross, N Fang, G A Koretzky.   

Abstract

We and others have shown that overexpression of SLP-76 augments TCR-stimulated IL-2 promoter activity in the Jurkat T cell line. In this report we investigate the signaling mechanisms through which SLP-76 mediates its effect on T cell activation. We show that overexpressed SLP-76 acts downstream of TCR-stimulated protein tyrosine kinases, but does not affect calcium signaling. Overexpression of SLP-76 does, however, augment TCR stimulation of both ERK (extracellular signal-regulated kinase) activity and a reporter construct driven by activating protein-1 binding sites. Structure/function analysis reveals that three distinct regions of SLP-76, each important for protein associations, are required for augmentation of TCR-induced nuclear factor-AT activity. These data suggest that SLP-76 functions as an adapter molecule that requires three unique domains to link proximal TCR signals in T cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257823

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Regulatory and signaling properties of the Vav family.

Authors:  X R Bustelo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 2.  Coordination of receptor signaling in multiple hematopoietic cell lineages by the adaptor protein SLP-76.

Authors:  Martha S Jordan; Gary A Koretzky
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-17       Impact factor: 10.005

3.  Sequential phosphorylation of SLP-76 at tyrosine 173 is required for activation of T and mast cells.

Authors:  Meirav Sela; Yaron Bogin; Dvora Beach; Thomas Oellerich; Johanna Lehne; Jennifer E Smith-Garvin; Mariko Okumura; Elina Starosvetsky; Rachelle Kosoff; Evgeny Libman; Gary Koretzky; Taku Kambayashi; Henning Urlaub; Jürgen Wienands; Jonathan Chernoff; Deborah Yablonski
Journal:  EMBO J       Date:  2011-07-01       Impact factor: 11.598

4.  Identification of a phospholipase C-gamma1 (PLC-gamma1) SH3 domain-binding site in SLP-76 required for T-cell receptor-mediated activation of PLC-gamma1 and NFAT.

Authors:  D Yablonski; T Kadlecek; A Weiss
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Persistence of cooperatively stabilized signaling clusters drives T-cell activation.

Authors:  Stephen C Bunnell; Andrew L Singer; David I Hong; Berri H Jacque; Martha S Jordan; Maria-Cristina Seminario; Valarie A Barr; Gary A Koretzky; Lawrence E Samelson
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

6.  Understanding signal integration through targeted mutations of an adapter protein.

Authors:  Tao Zou; Rebecca M May; Gary A Koretzky
Journal:  FEBS Lett       Date:  2010-10-21       Impact factor: 4.124

7.  Structural requirements of SLP-76 in signaling via the high-affinity immunoglobulin E receptor (Fc epsilon RI) in mast cells.

Authors:  Alexander Kettner; Vadim Pivniouk; Lalit Kumar; Hervé Falet; Jeng-Shin Lee; Richard Mulligan; Raif S Geha
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  Complementation in trans of altered thymocyte development in mice expressing mutant forms of the adaptor molecule SLP76.

Authors:  Martha S Jordan; Jennifer E Smith; Jeremy C Burns; Jessica-Elise T Austin; Kim E Nichols; Anna C Aschenbrenner; Gary A Koretzky
Journal:  Immunity       Date:  2008-03       Impact factor: 31.745

9.  Fetal hemorrhage and platelet dysfunction in SLP-76-deficient mice.

Authors:  J L Clements; J R Lee; B Gross; B Yang; J D Olson; A Sandra; S P Watson; S R Lentz; G A Koretzky
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  SLP-76-ADAP adaptor module regulates LFA-1 mediated costimulation and T cell motility.

Authors:  Hongyan Wang; Bin Wei; Georges Bismuth; Christopher E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.